扎鲁司特(zafirlukast,Accolate)适用于成人及12岁以上儿童慢性哮喘的预防和治疗。根据上市后监测报告,AstraZenecaCanadaInc公司对其产品说明作了相应修改。在“警告”栏中提示:当患者有肝功能不良体征或症状时,无须进一步确诊肝毒性,应该立即停用扎鲁司特。如果肝功能试验(血 Zafirlukast (Acflate) is suitable for the prevention and treatment of chronic asthma in adults and children over the age of 12 years. According to the post-market monitoring report, AstraZenecaCanadaInc its product description has been modified accordingly. In the “Warning” column, it is advised that zalutostate should be discontinued immediately when the patient has no further evidence of liver toxicity when the patient has signs or symptoms of liver dysfunction. If the liver function test (blood